Football
Chidera Ezeh happy with Porto move
Nigeria Under 20 international Chidera Ezeh has completed his move to Porto after appending his signature to a four-and-a-half-year deal with the Primeira Liga powerhouse in the January transfer window.
The attacker had to wait for about two years before penning a professional contract with the 27-time Portuguese champions, as he was yet to attain the age of majority when the club expressed interest in his signature after the 2013 Fifa U17 World Cup.
“Porto showed me love, they waited for me for two years after clinching the Under-17 World Cup. It shows they believed in me so much,” Chidera Ezeh said
“I will repay them by working hard every blessed day. I could not meet up with the start of pre-season training because it took four months before I was issued a visa.
“When I finally arrived in Portugal, I was told to start with the Under – 19s since I am still in the age bracket.
“I will move on to the second team when they see I am ready and I play much games, but surely next season I’ll fight for a place in the first team.”
The Nigeria Football Federation has already sent Chidera Ezeh’s International Transfer Certificate to Portugal, meaning his transfer to Porto is cast in stone.
-
Football7 days agoBallon d’Or 2026: Yamal, Mbappe, Kane emerge early favourites
-
Football6 days agoPost-World Cup Shake-Up: Managerial changes, record transfers dominate football headlines
-
Football6 days agoWAFCON 2026: Super Falcons target winning start as Nigeria face debutants Malawi
-
Energy5 days agoNigeria wastes enough gas to Ggenerate 62,400GWh of electricity amid deepening energy crisis — NOSDRA
-
Latest1 week agoAccountability group questions ₦962.8bn Allocation for empowerment projects, official vehicles in 2026 budget
-
Business2 days agoInformation Minister, VON DG to lead ARCON’s 2026 Advertising Industry Colloquium
-
Business3 days agoCooking gas dealers slash prices amid intensifying market competition
-
Health5 days agoFauci’s personal diaries fuel renewed scrutiny of COVID-19 vaccine safety


